Onderneming ClearPoint Neuro, Inc.
Aandelen
CLPT
US18507C1036
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,33 USD | -1,11% | -8,26% | -21,50% |
13/03 | CLEARPOINT NEURO, INC. : Stifel Nicolaus geeft koopadvies | ZM |
12/03 | ClearPoint Neuro, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 107
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biologics and Drug Delivery - Services and License
47,8
%
| 5 | 26,4 % | 11 | 47,8 % | +110,83% |
Functional Neurosurgery Navigation and Therapy - Disposable Products
31,7
%
| 8 | 36,9 % | 8 | 31,7 % | +0,03% |
Biologics and Drug Delivery - Disposable Products
9,0
%
| 4 | 18,0 % | 2 | 9,0 % | -41,63% |
Capital Equipment and Software - Services
4,1
%
| 1 | 3,9 % | 1 | 4,1 % | +22,39% |
Functional Neurosurgery Navigation and Therapy - Services
3,9
%
| 2 | 7,5 % | 1 | 3,9 % | -39,43% |
Capital Equipment and Software - Systems and Software Products
3,6
%
| 2 | 7,4 % | 1 | 3,6 % | -43,12% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 24 | 100,0 % | +16,56% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07-11-17 |
Director of Finance/CFO | 39 | 29-09-20 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 10-10-22 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
Jeremy Stigall
PRN | Corporate Officer/Principal | 41 | 01-07-20 |
General Counsel | - | 05-04-21 | |
Sales & Marketing | - | 01-11-19 | |
General Counsel | - | - | |
Robert Korn
SAM | Sales & Marketing | 58 | 12-11-12 |
Chris Yelley
PRN | Corporate Officer/Principal | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 01-09-19 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 15-07-21 |
R. Fletcher
CHM | Chairman | 78 | 09-05-17 |
Pascal Girin
BRD | Director/Board Member | 64 | 03-09-14 |
Timothy Richards
BRD | Director/Board Member | 66 | 10-03-14 |
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07-11-17 |
Matthew Klein
BRD | Director/Board Member | 52 | 16-04-20 |
Linda Liau
BRD | Director/Board Member | 57 | 02-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 069 568 | 25 012 797 ( 92,40 %) | 0 | 92,40 % |
Bedrijfsgegevens
Clearpoint Neuro, Inc.
120 South Sierra Avenue Suite 100
92075, Solana Beach
+
http://www.clearpointneuro.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,50% | 144 mln. | |
+2,64% | 208 mld. | |
+1,80% | 174 mld. | |
+8,59% | 130 mld. | |
+16,47% | 98,97 mld. | |
-3,42% | 60,46 mld. | |
+12,71% | 51,73 mld. | |
-6,61% | 45,33 mld. | |
-4,53% | 38,9 mld. | |
+9,27% | 38,56 mld. |
- Beurs
- Aandelen
- Koers CLPT
- Onderneming ClearPoint Neuro, Inc.